| typ : |
Czasopismo |
|
| Zespoły badawcze : |
Montreal - Faculté de pharmacie, Université de Montréal |
| Autorzy : |
Alarie H, Friciu M, Leclair G. |
| Tytuł : |
Stability of Dapsone in Extemporaneously Compounded Oral Suspensions. |
| Numer : |
Can J Hosp Pharm ;71,2/152-154 2018 |
|
| Poziom wiarygodności : |
|
| stabilność fizyczną : |
|
| Stabilność chemiczna : |
|
| Inne metody : |
|
| Komentarze : |
|
Listy
 Dapsone
|
 |
 |
 |
 |
60 mg
® = Jacobus Pharmaceutical |
|
23-27°C |
 |
| 90 |
 |
|
|
|
|
|
60 mg
® = Jacobus Pharmaceutical |
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
60 mg
® = Jacobus Pharmaceutical |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
60 mg
® = Jacobus Pharmaceutical |
|
3-7°C |
|
| 90 |
|
|
|
|
 |
|
2 mg
® = Jacobus Pharmaceutical |
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
2 mg
® = Jacobus Pharmaceutical |
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
2 mg
® = Jacobus Pharmaceutical |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
2 mg
® = Jacobus Pharmaceutical |
|
3-7°C |
|
| 90 |
|
|
|
|
|
